↓ Skip to main content

Antithrombotic treatment in elderly patients with atrial fibrillation: a practical approach

Overview of attention for article published in BMC Cardiovascular Disorders, November 2015
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (54th percentile)

Mentioned by

twitter
3 tweeters

Citations

dimensions_citation
53 Dimensions

Readers on

mendeley
129 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Antithrombotic treatment in elderly patients with atrial fibrillation: a practical approach
Published in
BMC Cardiovascular Disorders, November 2015
DOI 10.1186/s12872-015-0137-7
Pubmed ID
Authors

Carmen Suárez Fernández, Francesc Formiga, Miguel Camafort, Jose María Cepeda Rodrigo, Jesús Díez-Manglano, Antonio Pose Reino, Gregorio Tiberio, Jose María Mostaza

Abstract

Atrial fibrillation (AF) in the elderly is a complex condition. It has a direct impact on the underuse of antithrombotic therapy reported in this population. All patients aged ≥75 years with AF have an individual yearly risk of stroke >4 %. However, the risk of hemorrhage is also increased. Moreover, in this population it is common the presence of other comorbidities, cognitive disorders, risk of falls and polymedication. This may lead to an underuse of anticoagulant therapy. Direct oral anticoagulants (DOACs) are at least as effective as conventional therapy, but with lesser risk of intracranial hemorrhage. The simplification of treatment with these drugs may be an advantage in patients with cognitive impairment. The great majority of elderly patients with AF should receive anticoagulant therapy, unless an unequivocal contraindication. DOACs may be the drugs of choice in many elderly patients with AF. In this manuscript, the available evidence about the management of anticoagulation in elderly patients with AF is reviewed. In addition, specific practical recommendations about different controversial issues (i.e. patients with anemia, thrombocytopenia, risk of gastrointestinal bleeding, renal dysfunction, cognitive impairment, risk of falls, polymedication, frailty, etc.) are provided.

Twitter Demographics

The data shown below were collected from the profiles of 3 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 129 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 <1%
United States 1 <1%
Portugal 1 <1%
Slovenia 1 <1%
Unknown 125 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 22 17%
Student > Bachelor 18 14%
Researcher 14 11%
Other 14 11%
Student > Ph. D. Student 11 9%
Other 32 25%
Unknown 18 14%
Readers by discipline Count As %
Medicine and Dentistry 60 47%
Pharmacology, Toxicology and Pharmaceutical Science 12 9%
Nursing and Health Professions 11 9%
Psychology 4 3%
Social Sciences 3 2%
Other 10 8%
Unknown 29 22%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 October 2021.
All research outputs
#11,917,239
of 19,458,329 outputs
Outputs from BMC Cardiovascular Disorders
#526
of 1,280 outputs
Outputs of similar age
#148,072
of 297,777 outputs
Outputs of similar age from BMC Cardiovascular Disorders
#31
of 86 outputs
Altmetric has tracked 19,458,329 research outputs across all sources so far. This one is in the 36th percentile – i.e., 36% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,280 research outputs from this source. They receive a mean Attention Score of 3.7. This one has gotten more attention than average, scoring higher than 54% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 297,777 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 86 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 54% of its contemporaries.